Vascularized composite allotransplantation in children: what we can learn from solid organ transplantation

Area of Science:

• Pediatric transplantation
• Vascularized Composite Allotransplantation (VCA)
• Immunosuppression

Background:

• Decades of pediatric solid organ transplantation provide valuable insights.
• Emerging field of pediatric vascularized composite allotransplantation (VCA) presents new challenges and opportunities.
• Understanding the risk-benefit ratio of immunosuppression is critical for pediatric VCA.

Purpose of the Study:

• To review lessons learned from pediatric solid organ transplantation.
• To assess the relevance of these lessons to pediatric VCA.
• To evaluate the risk-benefit ratio of immunosuppression in pediatric VCA, distinguishing between life-enhancing and life-saving transplants.
• To consider potential indications for pediatric VCA.

Main Methods:

• Review of established knowledge in pediatric solid organ transplantation.
• Analysis of the first reported pediatric VCA case (bilateral upper extremity grafts, 2015).
• Consideration of immunosuppression risks and benefits in the context of pediatric VCA.

Main Results:

• The first pediatric VCA case demonstrated excellent early graft function and described cortical reorganization.
• This case involved a child with prior immunosuppression due to a kidney transplant.
• Immunosuppression remains a significant challenge for wider pediatric VCA application.

Conclusions:

• Careful consideration of indications and outcomes is essential for innovative pediatric VCA procedures.
• Pediatric VCA holds potential to restore form and function not otherwise achievable.
• Balancing the risks of immunosuppression with the benefits of VCA is crucial for advancing this field in children.